To study the comparison of efficacy and safety between injection iron sucrose complex and injection ferric carboxymaltose in the treatment of moderate anemia in pregnancy.

Comparative study of efficacy and safety between injection iron sucrose complex and injection ferric carboxymaltose in the treatment of moderate anemia in pregnancy. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064066

Enrollment

384

Registered

2024-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: inj.iron sucrose complex: inj.iron sucrose 1 ampule contains 100mg,maximum 200mg in 100ml 0.9%NS iv can be given single dose per sitting per day as per requirement of iron calculated b

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pregnant women between 16-34 weeks of gestation heamoglobin levels between 7-9gm/dl 2.microcytic and hypochromic picture in peripheral smears

Exclusion criteria

Exclusion criteria: 1.Anemia due to other causes-heamolytic,thalassemia,sickle cell disease,hypersplenism. 2.Infection and inflammation. 3.Liver and renal disease 4.Early pregnancy. 5.History of blood transfusion in present pregnancy. 6.History of allergy to inj.iron sucrose complex or inj.ferric carboxy maltose

Design outcomes

Primary

Measure	Time frame
To rise in heamoglobin level after injection iron sucrose & injection ferric carboxymaltose after 6weeks of treatment in both the groups.Timepoint: To rise in heamoglobin level after injection iron sucrose & injection ferric carboxymaltose after 6weeks of treatment in both the groups.	—

Secondary

Measure	Time frame
2.The rise in sr.ferritin levels after 6 weeks in both the study groups. 3.To study for the well being of the patient in terms of reduced fatigue,increased appetite. Timepoint: After 6 weeks of treatment	—

Countries

India

Contacts

Public ContactDr Suchita Sahebrao Sirsath

GMERS MEDICAL COLLEGE AND HOSPITAL GOTRI VADODARA.

Dipapitre@gmail.com9825569008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026